QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.060210v1 308/3/912    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anthonypillai, C. Articles by Thomas, S. A. Search for Related Content PubMed PubMed Citation Articles by Anthonypillai, C. Articles by Thomas, S. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

NEUROPHARMACOLOGY

The Distribution of the HIV Protease Inhibitor, Ritonavir, to the Brain, Cerebrospinal Fluid, and Choroid Plexuses of the Guinea Pig

Centre for Neuroscience Research, Guy's, King's and St. Thomas' School of Biomedical Science, King's College London, Guy's Hospital Campus, London, United Kingdom

Anti-human immunodeficiency virus (HIV) drug penetration into the brain and cerebrospinal fluid (CSF) is necessary to tackle HIV within the CNS. This study examines movement of [³H]ritonavir across the guinea pig blood-brain and blood-CSF barriers and accumulation within the brain, CSF, and choroid plexus. Ritonavir is a protease inhibitor, used in combination therapy (often as a pharmacoenhancer) to treat HIV. Drug interactions at brain barrier efflux systems may influence the CNS penetration of anti-viral drugs, thus the influence of additional protease inhibitors, nucleoside reverse transcriptase inhibitors, and non-nucleoside reverse transcriptase inhibitors on [³H]ritonavir CNS distribution was explored. Additionally, the involvement of transporters on [³H]ritonavir passage across the brain barriers was assessed. Results from in situ brain perfusions and capillary depletion analysis demonstrated that [³H]ritonavir uptake into the guinea pig brain was considerable (6.6 ± 0.7 ml/100 g at 30 min, vascular space corrected), although a proportion of drug remained trapped in the cerebral capillaries and did not reach the brain parenchyma. CSF uptake was more limited (2.2 ± 0.4 ml/100 g at 30 min), but choroid plexus uptake was abundant (176.7 ± 46.3 ml/100 g at 30 min). [³H]Ritonavir brain and CSF uptake was unaffected by neither inhibitors of organic anion transport (probenecid and digoxin) or P-glycoprotein (progesterone), nor by any additional anti-HIV drugs, indicating that brain barrier efflux systems do not significantly limit brain or CSF [³H]ritonavir accumulation in this model. [³H]Ritonavir uptake into the perfused choroid plexus was significantly reduced by nevirapine and abacavir, additional perfusion studies, and isolated incubated choroid plexus experiments were carried out in an attempt to further characterize the transporter involved.

Address correspondence to: S. A. Thomas, Centre for Neuroscience, Guy's, King's and St. Thomas' School of Biomedical Science, King's College London, Guy's Hospital Campus, London, UK. E-mail: sarah.thomas{at}kcl.ac.uk

This article has been cited by other articles:

				L. Sanderson, A. Khan, and S. Thomas Distribution of Suramin, an Antitrypanosomal Drug, across the Blood-Brain and Blood-Cerebrospinal Fluid Interfaces in Wild-Type and P-Glycoprotein Transporter-Deficient Mice Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3136 - 3146. [Abstract] [Full Text] [PDF]

				J. C. Kalvass, T. S. Maurer, and G. M. Pollack Use of Plasma and Brain Unbound Fractions to Assess the Extent of Brain Distribution of 34 Drugs: Comparison of Unbound Concentration Ratios to in Vivo P-Glycoprotein Efflux Ratios Drug Metab. Dispos., April 1, 2007; 35(4): 660 - 666. [Abstract] [Full Text] [PDF]

				J. E. Gibbs, Z. Gaffen, and S. A. Thomas Nevirapine Uptake into the Central Nervous System of the Guinea Pig: An in Situ Brain Perfusion Study J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 746 - 751. [Abstract] [Full Text] [PDF]